Chemicals · Founded 1961 · www.nocil.com · BSE 500730 · NSE NOCIL LTD · ISIN INE163A01018
No Notes Added Yet
Business
Nocil Ltd. is India's largest and leading manufacturer of a comprehensive range of rubber chemicals. The company's core business involves the production of rubber accelerators, antioxidants, and other specialty chemicals crucial for the performance and durability of rubber products. Its primary customers are companies in the tire manufacturing industry (globally and domestically) and the non-tire rubber processing sector (e.g., industrial products, footwear, cables). Nocil operates on a B2B model, supplying essential chemical ingredients that enhance rubber properties like strength, elasticity, and resistance to aging.
Revenue Mix
Nocil's business is predominantly focused on the "Rubber Chemicals" segment. The company manufactures a wide portfolio of products within this segment, including various types of accelerators (e.g., MBT, MBTS, CBS, TBBS), antioxidants (e.g., TDQ, IPPD, 6PPD), and anti-degradants. While the company does not typically break down its revenue into distinct segments like "tire chemicals" versus "non-tire chemicals," its offerings are broadly used across both parts of the rubber industry.
Industry
The rubber chemicals industry is characterized by significant technical expertise, high entry barriers (due to R&D, complex manufacturing, and stringent customer qualification processes), and a global oligopolistic structure. Nocil is a key global player and holds a dominant market leadership position in India across many of its product categories. It competes with other international chemical giants and also faces competition from Chinese manufacturers. The industry's demand is largely driven by the global automotive and general rubber goods sectors.
MOAT
Customer Switching Costs: Rubber chemicals are critical components for product performance, especially in tires. Once a chemical is approved and integrated into a customer's formulation, switching suppliers involves extensive re-qualification processes and potential performance risks, leading to high switching costs and sticky customer relationships.
Scale & Cost Efficiency: As India's largest producer with integrated manufacturing facilities (e.g., Dahej, Navi Mumbai), Nocil benefits from economies of scale and efficient operations.
R&D and Product Portfolio: Strong in-house R&D capabilities allow Nocil to offer a diverse and advanced product portfolio meeting specific customer requirements and staying competitive.
Environmental Compliance: Modern production facilities that adhere to stringent environmental norms, which is increasingly vital for gaining and retaining global customers.
Growth Drivers
Growth in Auto & Tire Industry: Increasing vehicle production (especially passenger vehicles and commercial vehicles), growing demand for replacement tires, and the ongoing radialization trend in India drive demand for rubber chemicals.
Global Export Opportunities: Leveraging competitive manufacturing and quality standards to expand presence and market share in international markets.
Capacity Expansion: Ongoing brownfield expansions at its manufacturing sites are aimed at increasing production capacity to meet growing domestic and international demand.
Import Substitution: Favorable government policies, such as "Make in India" initiatives and anti-dumping duties on certain imported chemicals, create opportunities for domestic manufacturers.
Non-Tire Rubber Sector Growth: Demand from other rubber applications like industrial goods, footwear, and cables also contributes to overall growth.
Risks
Raw Material Price Volatility: The company's profitability is susceptible to fluctuations in the prices of key petrochemical-derived raw materials (e.g., aniline, acetone, carbon disulfide), which are linked to crude oil prices.
Intense Competition: Competition from global majors and low-cost producers (particularly from China) can lead to pricing pressure and margin erosion.
Economic Cyclicality: Demand for rubber chemicals is closely tied to the health of the automotive industry and general economic conditions, making the company vulnerable to economic downturns.
Regulatory Changes: Stricter environmental regulations or changes in chemical safety standards could lead to increased compliance costs or operational restrictions.
Technological Obsolescence: Continuous investment in R&D is required to counter potential substitutes or to adapt to evolving customer needs and manufacturing processes.
Management & Ownership
Nocil Ltd. is part of the Arvind Mafatlal Group (AMG), a prominent Indian industrial conglomerate with a long-standing history. The company benefits from professional management, combining experienced industry veterans with a focus on operational excellence, R&D, and strategic expansion. The promoter group maintains a significant ownership stake, indicating long-term commitment and alignment of interests.
Outlook
Nocil is well-positioned in a critical B2B chemicals segment. The bull case rests on the robust long-term growth of the Indian and global automotive and tire industries, successful utilization of its expanded capacities, and benefits from import substitution policies. Its strong R&D capabilities, established customer relationships, and focus on high-quality products provide a resilient foundation. However, the bear case highlights vulnerabilities to global economic downturns impacting automotive demand, sustained volatility in raw material prices that cannot be fully passed on to customers, and potential for intensified competition leading to pricing pressures. Regulatory changes in environmental and chemical safety standards also present ongoing challenges.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 341 | 357 | 372 | 363 | 318 | 340 | 336 | 321 | 316 | 330 |
| Other Income | 6 | 25 | 9 | 8 | 9 | 6 | 7 | 10 | 6 | 14 |
| Total Income | 346 | 381 | 382 | 371 | 327 | 345 | 343 | 331 | 322 | 344 |
| Total Expenditure | 292 | 312 | 331 | 325 | 294 | 305 | 306 | 298 | 289 | 309 |
| Operating Profit | 55 | 69 | 50 | 46 | 33 | 40 | 37 | 33 | 33 | 35 |
| Interest | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 14 | 14 | 14 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 0 |
| Profit Before Tax | 41 | 56 | 37 | 32 | 19 | 26 | 23 | 19 | 13 | 21 |
| Provision for Tax | 11 | 14 | 10 | -10 | 6 | 5 | 6 | 6 | 4 | 4 |
| Profit After Tax | 30 | 42 | 27 | 42 | 13 | 21 | 17 | 12 | 9 | 17 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 30 | 42 | 27 | 42 | 13 | 21 | 17 | 12 | 9 | 17 |
| Adjusted Earnings Per Share | 1.8 | 2.5 | 1.6 | 2.5 | 0.8 | 1.2 | 1 | 0.7 | 0.6 | 1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 719 | 715 | 742 | 968 | 1043 | 846 | 925 | 1571 | 1617 | 1445 | 1393 | 1303 |
| Other Income | 4 | 4 | 10 | 15 | 10 | 9 | 15 | 4 | 6 | 39 | 32 | 37 |
| Total Income | 723 | 719 | 752 | 982 | 1053 | 855 | 939 | 1575 | 1623 | 1484 | 1425 | 1340 |
| Total Expenditure | 606 | 576 | 583 | 702 | 750 | 668 | 794 | 1285 | 1364 | 1250 | 1255 | 1202 |
| Operating Profit | 117 | 143 | 169 | 280 | 303 | 187 | 146 | 290 | 259 | 234 | 170 | 138 |
| Interest | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 0 |
| Depreciation | 14 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 56 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 |
| Profit Before Tax | 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 76 |
| Provision for Tax | 29 | 41 | 50 | 85 | 93 | 22 | 19 | 65 | 53 | 47 | 11 | 20 |
| Profit After Tax | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 55 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 55 |
| Adjusted Earnings Per Share | 3.6 | 4.9 | 5.9 | 10.3 | 11.2 | 7.9 | 5.3 | 10.6 | 9 | 8 | 6.2 | 3.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -4% | 10% | 7% |
| Operating Profit CAGR | -27% | -16% | -2% | 4% |
| PAT CAGR | -23% | -16% | -5% | 6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -20% | -10% | -5% | 12% |
| ROE Average | 6% | 8% | 9% | 12% |
| ROCE Average | 7% | 10% | 12% | 17% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 415 | 470 | 913 | 1047 | 1163 | 1185 | 1285 | 1445 | 1552 | 1699 | 1762 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 51 | 15 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 108 | 143 | 123 | 120 | 124 | 116 | 120 | 126 | 134 | 151 | 134 |
| Total Current Liabilities | 233 | 130 | 119 | 164 | 155 | 141 | 210 | 259 | 171 | 166 | 160 |
| Total Liabilities | 806 | 759 | 1161 | 1331 | 1442 | 1442 | 1615 | 1831 | 1857 | 2015 | 2057 |
| Fixed Assets | 311 | 307 | 542 | 527 | 657 | 797 | 917 | 909 | 887 | 869 | 855 |
| Other Non-Current Assets | 115 | 138 | 202 | 131 | 206 | 220 | 75 | 78 | 88 | 170 | 269 |
| Total Current Assets | 380 | 314 | 417 | 673 | 580 | 426 | 623 | 844 | 881 | 976 | 934 |
| Total Assets | 806 | 759 | 1161 | 1331 | 1442 | 1442 | 1615 | 1831 | 1857 | 2015 | 2057 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 14 | 5 | 4 | 106 | 24 | 37 | 9 | 45 | 12 | 24 | 92 |
| Cash Flow from Operating Activities | 30 | 170 | 142 | 102 | 164 | 179 | 94 | -30 | 282 | 201 | 26 |
| Cash Flow from Investing Activities | -5 | -12 | -10 | -142 | -101 | -106 | -62 | 31 | -217 | -77 | -37 |
| Cash Flow from Financing Activities | -33 | -151 | -31 | -43 | -50 | -101 | 0 | -34 | -54 | -55 | -50 |
| Net Cash Inflow / Outflow | -8 | 7 | 102 | -82 | 13 | -28 | 32 | -33 | 11 | 68 | -62 |
| Closing Cash & Cash Equivalent | 6 | 13 | 106 | 24 | 37 | 9 | 45 | 12 | 24 | 92 | 30 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.55 | 4.87 | 5.94 | 10.33 | 11.17 | 7.89 | 5.32 | 10.57 | 8.95 | 7.98 | 6.16 |
| CEPS(Rs) | 4.45 | 5.78 | 7.14 | 11.79 | 12.64 | 9.93 | 7.57 | 13.47 | 12.29 | 11.15 | 9.37 |
| DPS(Rs) | 1 | 1.2 | 1.8 | 2.5 | 2.5 | 2.5 | 2 | 3 | 3 | 3 | 2 |
| Book NAV/Share(Rs) | 25.81 | 29.23 | 55.66 | 63.42 | 70.05 | 71.22 | 76.96 | 86.48 | 92.8 | 101.53 | 105.01 |
| Core EBITDA Margin(%) | 14.42 | 17.67 | 19.46 | 26.83 | 28.07 | 21.06 | 14.15 | 18.21 | 15.63 | 13.5 | 9.87 |
| EBIT Margin(%) | 13.08 | 16.27 | 18.21 | 25.87 | 26.69 | 18.16 | 11.69 | 15.38 | 12.58 | 12.57 | 8.32 |
| Pre Tax Margin(%) | 10.98 | 15.08 | 17.94 | 25.75 | 26.63 | 18 | 11.59 | 15.31 | 12.5 | 12.46 | 8.2 |
| PAT Margin (%) | 7.27 | 9.92 | 11.87 | 17.18 | 17.72 | 15.44 | 9.56 | 11.21 | 9.23 | 9.21 | 7.39 |
| Cash Profit Margin (%) | 9.12 | 11.78 | 14.28 | 19.61 | 20.06 | 19.43 | 13.61 | 14.28 | 12.67 | 12.86 | 11.23 |
| ROA(%) | 7.42 | 10 | 10.12 | 13.64 | 13.33 | 9.06 | 5.78 | 10.22 | 8.09 | 6.87 | 5.05 |
| ROE(%) | 14.41 | 17.69 | 14.07 | 17.4 | 16.79 | 11.18 | 7.19 | 12.95 | 9.99 | 8.21 | 5.97 |
| ROCE(%) | 18.74 | 24.04 | 20.84 | 25.85 | 25.14 | 13.09 | 8.75 | 17.71 | 13.56 | 11.17 | 6.7 |
| Receivable days | 73.18 | 73.65 | 70.83 | 75.62 | 83.22 | 93.89 | 101.01 | 88.08 | 89.84 | 86.68 | 85.23 |
| Inventory Days | 80.84 | 74.14 | 55.14 | 49.78 | 57.04 | 66.23 | 59.62 | 57.89 | 69.73 | 64.13 | 66.06 |
| Payable days | 71.63 | 64.94 | 62.2 | 53.3 | 54.23 | 71 | 71.68 | 57.73 | 52.57 | 41.66 | 35.94 |
| PER(x) | 10.6 | 9.47 | 15.81 | 18.52 | 13.17 | 8.34 | 32.83 | 23.59 | 23.05 | 31.24 | 28.4 |
| Price/Book(x) | 1.46 | 1.58 | 1.69 | 3.02 | 2.1 | 0.92 | 2.27 | 2.88 | 2.22 | 2.46 | 1.67 |
| Dividend Yield(%) | 2.66 | 2.6 | 1.92 | 1.31 | 1.7 | 3.8 | 1.15 | 1.2 | 1.45 | 1.2 | 1.14 |
| EV/Net Sales(x) | 1.04 | 1.06 | 1.92 | 3.22 | 2.3 | 1.27 | 3.05 | 2.63 | 2.09 | 2.81 | 2.07 |
| EV/Core EBITDA(x) | 6.38 | 5.3 | 8.46 | 11.15 | 7.91 | 5.74 | 19.39 | 14.27 | 13.05 | 17.32 | 17.04 |
| Net Sales Growth(%) | 20.61 | -0.53 | 3.78 | 30.37 | 7.78 | -18.85 | 9.26 | 69.93 | 2.88 | -10.63 | -3.6 |
| EBIT Growth(%) | 95.96 | 24.85 | 16.15 | 71.76 | 8.77 | -44.8 | -29.65 | 123.6 | -15.9 | -10.66 | -36.17 |
| PAT Growth(%) | 139.37 | 37.06 | 24.1 | 74.97 | 8.78 | -29.31 | -32.34 | 99.2 | -15.31 | -10.83 | -22.66 |
| EPS Growth(%) | 139.36 | 37.06 | 21.98 | 74.01 | 8.16 | -29.39 | -32.59 | 98.78 | -15.34 | -10.83 | -22.83 |
| Debt/Equity(x) | 0.36 | 0.07 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.63 | 2.41 | 3.49 | 4.09 | 3.74 | 3.03 | 2.96 | 3.26 | 5.15 | 5.89 | 5.82 |
| Quick Ratio(x) | 0.83 | 1.39 | 2.53 | 3.15 | 2.64 | 2.06 | 2.17 | 1.97 | 3.49 | 4.55 | 4.07 |
| Interest Cover(x) | 6.22 | 13.73 | 67.12 | 209.77 | 441.86 | 116.41 | 111.44 | 221.75 | 169.41 | 112.1 | 64.77 |
| Total Debt/Mcap(x) | 0.25 | 0.04 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 33.84 | 33.84 | 33.84 | 33.79 | 33.78 | 33.76 | 33.76 | 33.76 | 33.76 | 33.76 |
| FII | 6.98 | 7.78 | 7.77 | 7.91 | 7.81 | 8.15 | 6.65 | 5.15 | 4.47 | 4.55 |
| DII | 2.83 | 3.51 | 4.44 | 6.13 | 5.91 | 5.26 | 5.18 | 6.55 | 6.48 | 7.89 |
| Public | 56.35 | 54.88 | 53.96 | 52.17 | 52.5 | 52.83 | 54.41 | 54.54 | 55.29 | 53.79 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 |
| FII | 1.16 | 1.3 | 1.29 | 1.32 | 1.3 | 1.36 | 1.11 | 0.86 | 0.75 | 0.76 |
| DII | 0.47 | 0.58 | 0.74 | 1.02 | 0.99 | 0.88 | 0.86 | 1.09 | 1.08 | 1.32 |
| Public | 9.39 | 9.15 | 8.99 | 8.71 | 8.77 | 8.82 | 9.09 | 9.11 | 9.23 | 8.98 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16.66 | 16.66 | 16.66 | 16.69 | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -4% | -4% | +10% | +7% |
| Operating Profit CAGR | -27% | -16% | -2% | +4% |
| PAT CAGR | -23% | -16% | -5% | +6% |
| Share Price CAGR | -20% | -10% | -5% | +12% |
| ROE Average | +6% | +8% | +9% | +12% |
| ROCE Average | +7% | +10% | +12% | +17% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 33.84 | 33.84 | 33.84 | 33.79 | 33.78 | 33.76 | 33.76 | 33.76 | 33.76 | 33.76 |
| FII | 6.98 | 7.78 | 7.77 | 7.91 | 7.81 | 8.15 | 6.65 | 5.15 | 4.47 | 4.55 |
| DII | 2.83 | 3.51 | 4.44 | 6.13 | 5.91 | 5.26 | 5.18 | 6.55 | 6.48 | 7.89 |
| Public | 66.16 | 66.16 | 66.16 | 66.21 | 66.22 | 66.24 | 66.24 | 66.24 | 66.24 | 66.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 |
| FII | 1.16 | 1.3 | 1.29 | 1.32 | 1.3 | 1.36 | 1.11 | 0.86 | 0.75 | 0.76 |
| DII | 0.47 | 0.58 | 0.74 | 1.02 | 0.99 | 0.88 | 0.86 | 1.09 | 1.08 | 1.32 |
| Public | 11.03 | 11.03 | 11.03 | 11.05 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16.66 | 16.66 | 16.66 | 16.69 | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.